Keeping in mind that these results were obtained in a PD-animal model, they can partly explain discrepancies in the existing data, and strongly corroborate the fact that inhibition of S6K1 does not recapitulate rapamycin actions. This evidence concerns the gene RPS6KB1 and Parkinson disease.